| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583935 | Seminars in Arthritis and Rheumatism | 2017 | 27 Pages |
Abstract
TNF antagonists were efficacious in about two-thirds of patients with severe/refractory sarcoidosis but their use led to a high rate of adverse events.
Keywords
CZPWASOGTNFTNF antagonistAZACYCleflunomideCertolizumab pegolETNMTXAdalimumabIFXMMFIQRAesazathioprineetanerceptEfficacySafetyInfliximabCNSSarcoidosiscentral nervous systemCyclosporineCyclophosphamideAdverse eventsconfidence intervaltumor necrosis factorLefmycophenolate mofetilMethotrexateinterquartile rangeodds ratioADACorticosteroids
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Yvan MD, Fleur MD, PhD, Catherine MD, Delphine MD, PhD, Alicia MD, Laurent MD, Laurence MD, PhD, Alban MD, Sébastien MD, PhD, Philip MD, Diane MD, Marc MD, PhD, Nicolas MD, Boris MD, PhD, Alice MD, Sandra MD, PhD, Bahram MD, PhD, Françoise MD, PhD,